Event Date/Time: Nov 16, 2011 | End Date/Time: Nov 18, 2011 |
Description
Part Two: This examines advances in predictive immunogenicity and means of controlling it with a wide range of approaches. Sub-visible particles and aggregates are becoming extremely hot, especially from a regulatory perspective so attention will be paid to their assessment and characterization. Additional topics of increasing interest such as the link between formulation and immunogenicity, and the uncertain immunogenicity of the new generation of novel antibody constructs will be presented together with means of engineering new products to mitigate against immunogenicity.